Revvity, Inc.

Revvity, Inc. is a science-based solutions company that supplies the life sciences and diagnostics fields across the full research-to-treatment continuum, from research discovery through development, diagnosis and cure. Its portfolio spans reagents and consumables, assays for research and clinical applications, scientific and diagnostic instruments with automation capabilities, and the Signals software business, which supports research data and decision-making across the research-to-clinical continuum.

For technical and computational candidates, the relevant domains are automation, multi-omics, scientific software, assay development and instrumentation, alongside translational and preclinical research. The company describes itself as a translational enterprise bridging research and clinical customers, and emphasises collaboration across its automation, multi-omics and Signals software businesses.

Revvity reports revenue of over $2.9 billion and employs more than 11,000 people globally, with its headquarters in Waltham, Massachusetts and customers in more than 190 countries. Its customers include pharmaceutical and biotechnology companies, diagnostic laboratories, academia, government agencies and organisations in life sciences research and clinical diagnostics.

The name Revvity combines "rev", from revolutionise, with "vita", Latin for "life", reflecting a stated mission of improving lives everywhere.